Labrador, Jovie D.
HRN: 22-55-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2023
CEFUROXIME 1.5GM (VIAL)
01/27/2023
01/29/2023
IV
1.5 G
Q8 X 6 Doses
Sp LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes